Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cabergoline Versus GnRH Antagonist Rescue and Cabergoline in the Prevention of Ovarian Hyperstimulation Syndrome: a Randomized Controlled Trial

NCT02461875 is registered in ClinicalTrials.gov with Aljazeera Hospital as lead sponsor.

NCT NCT02461875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02461875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cabergoline Versus GnRH Antagonist Rescue and Cabergoline in the Prevention of Ovarian Hyperstimulation Syndrome: a Randomized Controlled Trial
Lead sponsor
Aljazeera Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
May 31, 2013
Completion date
December 31, 2015
Enrollment
236 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ohss